Clinical Trial Update: Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating the safety of DEXYCU for inflammation after ocular surgery in childhood cataract, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Dexycu (dexamethasone intraocular suspension)

Snippet

Sponsor: EyePoint Pharmaceuticals, Inc. | Conditions: Cataract | Phase 4 | Status: RECRUITING